Cancer Conference | Epigenetics Conferences | 2017 | Cancer Genetics | Cancer Epigenetics | Epigenetics | Japan | Asia Pacific | Osaka | Cancer meetings | Europe

Quick Links

Epigenetics Cancer 2017 workshop

Epigenetics Cancer 2017

International Conference on Cancer Genetics and Epigenetics

Keynote Speaker

Avail early bird benefits

Epigenetics Cancer 2017 collaboration

Epigenetics and Cancer 2017

Epigenetics Cancer 2017

Theme: From Novel therapies to Revolutionary Strategies , Diagnosis and Treatment

Epigenetics and Cancer 2017

Final Program 2017

Renowned Speakers

Dr. Mukesh Verma
National Cancer Institute (NCI). National Institutes of Health (NIH)
USA

Dr. Jyotdeep Kaur
Postgraduate Institute of Medical Education and Research
India

Dr.Atsushi Kaneda
Chiba University,
Japan

Dr. Jenny Y. Wang
University of New South Wales
Australia

Epigenetics and Cancer 2017

Dear Colleagues and Scientists,

Welcome to the "International Conference on Cancer Genetics and Epigenetics"

On behalf of the Conference Organizing Committee, it is my honor and privilege to welcome you to this conference. This event is an exciting opportunity for Leaders in this field to synergize and deepen their understanding of Epigenetics and Cancer through discussions, presentations, workshops and poster sessions.

The Epigenetics Cancer 2017 Conference is the premiere destination to share your excitement in promoting your company and ideas with Eminent Scientists, Research Scholars & Related Companies. The International Oncology Community is very grateful to the Conference Venue and its Organizing Committee for providing us with this opportunity to come together and share experiences for enhancing our skills as Oncologists, Scientists and Researchers in order to strengthen our understanding of vital issues related to “Epigenetics & Cancer”.

David A Ligon,

Founder & CEO Oncology Fox,

USA

Track 1 : Cancer

Cancer is an abnormal growth of cells which have a tendency to multiply in an uncontrolled way. They have a property to metastasize. The branch of medicine that deals with the prevention, diagnosis and treatment of Cancer is called Oncology.

It is a group of different, distinct diseases.
It can arise in any tissue and organ.
Benign.
Malignant.

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Track 2 : Types of Cancer

Cancers are classified and named depending upon the type of cell they originated and have different forms. Some examples are as follows:

Bone Cancer
Brain Tumors
Breast Cancer
Cervical Cancer
Leukemia
Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Retinoblastoma
Skin Cancer
Thyroid Cancer
Vaginal Cancer

9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Track 3 : Cancer Genetics

Certain changes to genes can alter and control the functioning of the body cells, their growth and division. This causes Cancer.

Cancer causing genetic changes :

Mutations
Germ Line Changes
Hereditary Cancer Syndrome
Exposure to Certain substances like radiation, UV rays etc.

Track 4 : Cancer : Diagnostics and Staging

Cancer is suspected in a view of a persons symptoms ,screening tests. Affirmation that Cancer is present requires diagnostic tests which is followed by staging. Staging is way of analysing the tumor, its size, location and the treatment depending on the Cancer stage.It helps to determine the Prognosis of the patient i,e treatment prediction ,disease outcome and patients recovery chances.

Track 5 : Cancer: Treatment and Therapy

There are many sorts of Cancer treatment. The treatment varies depending on the type of Cancer and its stage.The following are the main types of Cancer treatment :

Surgery
Radiation Therapy
Immunotherapy
Chemotherapy
Hormone Therapy
Targeted Therapy
Stem Cell Transplant
Precision Medicine

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA;.

Track 6 : Cancer Stem Cells

Cancer Stem Cells are Cancer cells present in the tumors. They possess the normal stem cells characteristic’s i,e their ability to proliferate into different cell types by differentiation.Cancer stem cells are tumorigenic and develops tumors. They also lead to metastasis and relapse thus giving rise to the formation of new tumor cells.Hence there is a need to develop specific therapies targeted at Cancer stem cells to increase the chances of survival of Cancer patients.

Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain;

Track 7 : Cancer Epigenetics

The study of epigenetic modifications to the Cancer cells genome is called Cancer Epigenetics, that does not bring a change in the nucleotide sequence. Risk expectation and prediction and Cancer prevention, growth counteractive action are also promising and encouraging areas of Epigenetics.A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors.

During the cell’stransformation to Cancerous cell, Epigenetic modifications are also mor important like genetic mutation’s. Their manipulation brings a great promising approach to for preventing , detecting and therapy of Cancer.

19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Track 8 : Epigenetics

Epigenetics deals with the study of heritable changes in gene , that does not include changes to the basic DNA arrangement — an adjustment in phenotype without an adjustment in genotype — which influences how cells read the genes. Epigenetics change is a normal, natural and characteristic occurence yet can likewise be affected by a few factors including age, the environment/lifestyle, and illness state. Epigenetics modifications can show as normally as the way in which cells terminally separate to differentiate as liver cells, skin cells, etc.Alternately, epigenetic change can have all the more harming impacts that can bring illnesses, disease.

example :Cancer.

Track 9 : Developmental and Nutritional Epigenetics

Epigenetic factors are also called as epigenetic marks control many functions of cells in our bodies. From time to time, Epigenetic marks cause certain genes to be turned on or off at various phases of the body's development and growth in a way that prompts to a disease onset

In this way, researchers and scientists have been able to find the thin line which is connecting the following diseases to Epigenetics

Autism
ATR-X syndrome
Angelman syndrome
Beckwith Wiedemann syndrome
Coffin-Lowry syndrome
Fragile X syndrome
Heart disease
Obesity
Prader-Willi syndrome
Rett syndrome
Rubinstein-Taybi syndrome
Various Cancers

This track also deals with the modification’s and changes that greatly affects the processes such as DNA methylation and histone modifications like embryonic development, aging, and carcinogenesis

Epigenetics plays a key role in wide range of diseases like type 2 Diabetes Mellitus, Obesity, inflammation, and neurocognitive disorders. Nutritional Epigenetics can be considered as an attractive tool to anticipate and prevent Cancer and pediatric developmental diseases

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Track 10 : Transgenerational Epigenetic inheritance

Transgenerational epigenetic inheritance is the transmittance of information from one generation to another ,for example :from a parent to child.This affects the offsprings’traits without changing the primary structure of DNA.In multicellular organisms the epigenetic inheritance has different mechansisms.

Track 11 : Epigenetics - Neurodevelopmental and Neurodegenerative disease

Neurodegenerative disorders are among the major difficulties and among the most medical issues that should be withstanded by the world, particularly in light of expanding population age. They cause the degeneration and death of nerve cells as they form incurable conditions for treatment. According to a collaborative study of the WHO, the World Bank and the Harvard School of Public Health by 2020 neurodegenerative diseases,dementia will be the eighth cause of disease among developed regions.It is also estimated that they will occupy the world’s second leading cause of death by 2050, overtaking Cancer During embryogenesis and for differentiation of neural cells Epigenetic mechanisms are essential required. Thus, precise understanding of epigenetic mechanisms, including DNA methylation and histone modification, is important to elucidate the pathogenic pathways in neurodevelopmental disorders

Most common neurodegenerative diseases

Parkinson's disease
Alzheimer disease.
Huntington disease

Track 12 : Epigenetic –Diseases, Clinical Applications , Pharmacogenomics

This particular track deals with the onset of diseases and the required clinical applications and theraphy related to those diseases.

Pharmacogenomics is a combination of pharmacology and genomics.this branch of study is concerned with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacodynamics and pharmacokinetics. The genetic disorder occurrence is quite rare in polutaion.Some might be hereditary while the others are caused by mutations.

Track 13 : Biomarkers and Bioinformatics Development in Epigenetics

Histones and DNA are chemically altered with epigenetic markers. They influence chromatin structure by changing the electrostatic nature of the chromatin or by altering the affinity of chromatin-binding proteins. DNA can be modified by methylation of cytosine bases

This track also deals with Bioinformatics role in Epigenetics.This branch is expected to make significant contributions to Epigenetics research. Studies in computational Epigenetics involves the improvement and utilization of bioinformatics strategies for resolving the epigenetic questions, and in addition computational information examination and hypothetical displaying with regards to Epigenetics. This incorporates the effects of histone and DNA CpG island methylation.

15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK; 16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan.

Track 14 : Epigenomic Effects of Environmental Exposures

Environmental contaminants and toxicants are far reaching all through the world, and can incorporate different materials and chemicals, from by results of ignition to contaminationg trace metals and organic natural mixes utilized as a part of day by day life. Presentation to changing sums and sorts of these contaminants is connected to impacts on human wellbeing .The fields of natural wellbeing and toxicology have concentrated on bettering the comprehension of how these contaminants affect biological prcocesses so that their wellbeing effects can be lessened or anticipated.

Numerous diseases are brought about by various types of alterations among dfifferent genes. Some of these progressions are hereditary changes that are passed along in families while some are mutations that happen due various hazardous environmental factors .

Track 15 : World Cancer Market

Oncology Market is increasing and will be paced on a wide scale.The world wide oncology market is expected to grow in upcoming years due to expanded industry R&D and high investments by multinational companies in the Cancer research.

An increase in Oncology market is also due to following reasons:
Longer life expectancies
Enhancing existing treatments by minimizing the side effects.
Increased levels of Innovation through 2020 More supportive care
Target oriented medicine
Treatment methods which enhance the immune system’s response towards tumor cell

Track 16 : Entreprenuers Investment Meet

A stage planned to associate Entrepreneurs, Proposers and the Investors around the world. It's expected to make and encourage the most streamlined and reasonable meeting place for drawing in individuals in worldwide business disdcussions, assessment and execution of promising business thoughts. A financial specialist might discover the most astounding potential venture openings all around, which give great quantifiable profit. For business visionaries, this would be a perfect place to discover appropriate speculators and accomplices to begin or potentially extend their business. Hence it is an impeccable place to associate Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.

Epigenetics and Cancer 2017 is delighted to announce the International Conference on Cancer Genetics & Epigenetics which will be held between October 26-28, 2017 at Osaka, Japan. It is our pleasure to welcome you to take part in this conference. This gathering at Osaka, Japan will continue for three days which includes prompt Keynote Presentations, Poster Presentations, E-poster, Oral talks, Symposia, Workshop, Scientific meetings and Exhibitions.

Epigenetics and Cancer 2017 is organized with the theme “From Novel therapies to Revolutionary Strategies , Diagnosis and Treatment”. This conference is comprised of many interactive sessions related to Cancer Genetics and Epigenetics which comprises a broad range from novel advancements to various strategies for diagnosis and treatment.

Goal of the conference

The central goal of this conference is to give a universal discussion for cutting edge research and inquire about Cancer Genetics and Epigenetics. This gathering gives "the central point" for individuals to introduce their examination and research thoughts. Purpose of this event is to strengthen new perspectives for treatment that will be significant over the scope of Epigenetics and Cancer.

Why to attend?

Epigenetics and Cancer 2017 Conference is a novel discussion to unite overall recognized scholastics in the field of Oncology, Epigenetics and Genetics Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars to to exchange about state of the Research and Development. The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We like wise incorporate talks on most recent methodologies for concentrating these biological inquiries. We encourage multidisciplinary approach as well. A Unique Opportunity for Advertisers and Sponsors at this International event.

Target Audience

• Scientists

• Professors and Students from Academia

• Epi Genetics ,Genetics and Oncology Researchers

• Human Genetics/ Epigenetics/Cancer Associations and Societies

• Business Entrepreneurs & Allied health professionals.

• Training Institutes

• Software developing companies

• Business delegates

• Data Management Companies

• Pharmaceutical Companies

• Diagnostics Companies

• Industrial Leaders

• Medical Colleges

• Molecular Biologists,

• CEO's ,directors and R&D Heads

Epigenetics and Cancer 2017 are organized by ConferenceSeries Ltd which is comprised of 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field all over the globe.

In the last few years, the market for Cancer profiling in Asia-Pacific region has seen huge development as a result of increasing incidence of Cancer, high demand for better healthcare services .

High prevalence of Cancer; expanding R&D subsidizing; expanding power of research exercises; expanding application for non-oncology illnesses; and developing organization between scholarly, biotechnology and pharmaceutical organizations are driving components of the Cancer genomics and epigenetics market

Cancer Profiling Market is divided by Application ,Diagnosis, Technique, Technology etc.

By Application it consists of :

Diagnostic,
Personalized Medicine,
Research.

By Technique, it consists of :

Genomics,
Proteomics,
Metabolomics,
Epigenetics.

By Technology, it consists of :

Next-generation Sequencing,
qPCR,
In-situ Hybridization,
Microarray

It is estimated that the worldwide Cancer Profiling business sector is ready to achieve USD 61.87 Billion by 2021 from USD 25.82 Billion in 2016 according to the "Cancer Profiling Market".The following graph depicts the data pictorially.

Central point powering market development are increasing number of malignancy cases over the globe.

Components, for example, the expanding interest for personalized medicine and point-of-care diagnostic tests in Cancer profiling are required to offer an extensive variety of development open doors for players in the tumor profiling market. The personalized medicine segment to represent the biggest share of the worldwide cancer profiling application showcase in 2016.

Across the board continuous research in the part of Epigenetics in diseases and disorders in humans is fuelling the worldwide epigenetics drugs, diagnostic technologies and indicative advances.

In light of research territories, the market for Epigenetics is fragmented into developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.

In light of geology, the market of Epigenetics is divided into North America, Europe, Asia, and the Rest of the World. North America is further sub-segmented into U.S. furthermore, Canada. In Asia, the degree for this present market's development is extending quickly. Asia represents about a large portion of all cancer cases analyzed around the world. This makes helpful conditions for the development of the Epigenetic medications and diagnostics advertise in Asian nations, particularly China, Japan, Australia, and South Korea, with Japan in the prevailing position.

As per the National Cancer Institute, malignancy is among the main sources of death around the world, for which according to a recent review, epigenetic inhibitors comprise of the attributes and capacities which have the potential in cancer prevention and control. This element has given an impulse to the examination directed on epigenetics in the oncology business

In the estimated period between 2015 to 2020 the Epigenetics market is relied upon to stay as the quantity of new participants in this market will continue ascending with the consistent appearance of new innovations combined with upgraded highlights.

The Asia Pacific market is estimated to witness lucrative growth over the forecast period owing to, the presence of large prevalence of target diseases and high unmet medical needs. Technology progressions in the field of epigenetics particularly relating to the location of methylation markers identified with growth advancement is relied upon to enhance utilization rates.

Epigenetic reagents was the biggest market esteemed at over USD 1.2 billion in 2014 attributable to the expanding measure of R&D ventures and high utilization rates. Kits are relied upon to increase quick development sought after because of the expanding need of rapid and accurate detection techniques..

DNA methylation was the biggest innovation portion representing more than 47.0% income in 2014.Oncology was the biggest application showcase, with income esteemed at over USD 2.75 billion. Non oncology segment is anticipated to register the fastest development of over 20.0% during the forecast period. The segment is dominated by metabolic diseases owing to, the growing base of population suffering from diabetes and organ failure and increasing prevalence of sedentary lifestyle.

Owing to the increasing economic burden of diseases such as cancer and diabetes, governments across the world are advocating the adoption of early disease detection and diagnosis. Early cancer detection, especially, is being encouraged through screening kits. This is helping the development of the worldwide epigenetics drugs and indicative advancements advertise, states the report.

The overall business division of Epigenetics is divided in light of items, research domains and topography. By item, the business area consolidates catalysts, instruments and consumables, packs and reagents.Instruments and consumables are further subsegmented into mass spectrometers, cutting edge sequencers, qPCRs, sonicators and different epigenetics instruments and consumables.Other research zones consolidate expansive managerial instruments and research related to metabolic and inherited diseases.

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)

· Reagents

· Kits

· Instruments

· Enzymes

· Services

Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)

· DNA Methylation

· Histone Methylation

· Histone Acetylation

· Large noncoding RNA

· MicroRNA Modification

· Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)

· Oncology

· Solid Tumors

· Liquid Tumors

· Non Oncology

· Inflammatory Diseases

· Metabolic Diseases

· Infectious Diseases

· Cardiovascular Diseases

Epigenetics Market Regional Outlook (Revenue, USD Million, 2015 – 2022)

· North America

· U.S.

· Canada

· Europe

· UK

· Germany

· Asia Pacific

· Japan

· China

· India

· Latin America

· Brazil

· Mexico

· Middle East and Africa (MEA)

· South Africa

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 26-28 2017
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

International Conference on Cancer Genetics and Epigenetics October 26-28 2017 Osaka,Japan

Recommended Global Oncology & Cancer Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Epigenetics Cancer 2017 workshop

Epigenetics Cancer 2017

International Conference on Cancer Genetics and Epigenetics

Keynote Speaker

Avail early bird benefits

Epigenetics Cancer 2017 collaboration

Epigenetics and Cancer 2017

Epigenetics Cancer 2017

Renowned Speakers

Epigenetics and Cancer 2017

Dear Colleagues and Scientists,

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Association with

Association with

Association with

Useful Links

Special Issues